News Alpha Tau Medical Ltd.

Equities

DRTS

IL0011839383

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-01 pm EDT			5-day change	1st Jan Change
2.43 ^USD	-2.80%		-2.41%	-19.27%

Mar. 07	Alpha Tau Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Alpha Tau Medical Ltd. Announces Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alpha Tau to Participate in May Investor Conferences	08:30am	AQ
Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit	Mar. 25	AQ
Alpha Tau Medical : to Present at the Jefferies Radiopharma Innovation Summit - Form 6-K	Mar. 25	PU
Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update	Mar. 07	AQ
Alpha Tau Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
Alpha Tau Medical : Corporate Presentation – March 2024	Mar. 03	PU
Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference	Feb. 26	AQ
Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Dec. 20	GL
Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Dec. 20	AQ
Alpha Tau to Participate in Sidoti Small-Cap Conference	Nov. 29	AQ
Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer	Nov. 28	GL
Alpha Tau Medical Ltd. Announces Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer	Nov. 28	CI
Alpha Tau, HekaBio Seek Japan's Premarket Approval of Alpha-Radiation Therapy for Head, Neck Cancer	Nov. 20	MT
Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer	Nov. 20	GL
Alpha Tau Medical Ltd. Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer	Nov. 20	CI
Piper Sandler Adjusts Alpha Tau Medical's Price Target to $8 From $12, Keeps Overweight Rating	Nov. 17	MT
Alpha Tau Medical Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	Nov. 16	CI
Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update	Nov. 16	AQ
Alpha Tau to Participate in November Investor Conferences	Nov. 01	AQ
Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing Facility	23-10-30	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Alpha Tau Medical Ltd.

Equities

DRTS

IL0011839383

Summary

Filters